Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

EW Relative to the S&P 500

EW Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Edwards Lifesciences Corp. (NYSE:EW) seasonal charts above shows that a Buy Date of December 2 and a Sell Date of April 21 has resulted in a geometric average return of 8.13% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 18 of those periods. This is an excellent rate of success, but the return underperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 1.09% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient’s heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

To download EW seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: EW